Clyde Frazier's Rea...
Health Care: Drugs
Martek Biosciences Corporation (MATK: NASDAQ)
$31.49 -0.01 | -0.03%
02/25/11 - 04:00 PM ET
308.07K / 1.08M
Vol / Avg. Vol:31.54 / 31.50
Open / Prev. Close:31.48 - 31.54
Today's Range:17.95 - 32.75
52 Wk Range:0.61%
Performance YTD:TheStreet Rating:
Portfolios with MATK
- Portfolio NameUser Type
- ContributorEarnings Short Squeeze Play...
- ContributorTheStreet Ratings Top-Rated...
- UserPelican Portfolio 1
- UserTop Biotech Short Squeeze P...
- UserTop NASDAQ Short Squeeze Pl...
- ContributorBarron's Summary 3-28-2009
- UserTop NASDAQ Short Squeeze Pl...
- UserETles
- UserTop Year End NASDAQ Short S...
- UserNASDAQ Short Squeeze Plays ...
Latest MATK Headlines from TheStreet
- Stocks Under $10: Growth Name on Sale
03.01.11 | 02:03 pm - Stocks Under $10: Growth Name on Sale 03.01.11 | 02:03 pm
- Stocks Under $10: Growth Name on Sale 03.01.11 | 01:03 pm
- Stocks Under $10: Growth Name on Sale 03.01.11 | 12:03 pm
- Stock Market, Feb. 28: What's on Tap 02.27.11 | 07:02 pm
- Stock Market, Feb. 28: What's on Tap 02.27.11 | 07:02 pm
- Insiders Trading MATK, VMI, CTGO, GOOG 02.25.11 | 09:02 am
- Dow Marches Higher on M&A, Earnings 12.21.10 | 04:12 pm
- Martek Biosciences: Premarket Trading 12.21.10 | 07:12 am
- DSM Offers to Buy Martek for $1.09B 12.21.10 | 03:12 am
Press Releases for MATK
- Egleston Law Firm Announces Investigation Of The Acquisition Of Martek Biosciences Corporation - Business Wire 12.30.10 | 06:12 pm
- Bull & Lifshitz, LLP Announces Investigation Of The Acquisition Of Martek Biosciences Corporation - Business Wire 12.28.10 | 12:12 pm
- Ryan & Maniskas, LLP Announces Investigation Of Martek Biosciences Corp. - Business Wire 12.22.10 | 03:12 pm
- The Law Office Of Joseph Klein Is Investigating Possible Breaches Of Fiduciary Duty By The Board Of Martek Biosciences Corporation In Connection With The Sale Of The Company To Royal DSM N.V. – MATK - Business Wire 12.22.10 | 12:12 pm
- The Law Firm Of Weiss & Lurie Investigates The Acquisition Of Martek Biosciences Corporation By Royal DSM N.V. - Business Wire 12.22.10 | 11:12 am
- Briscoe Law Firm Investigates Martek Biosciences For Shareholders - Business Wire 12.22.10 | 10:12 am
- The Law Office Of Abe Shainberg Launches An Investigation Into The Possible Breaches Of Fiduciary Duty By The Board Of Martek Biosciences Corporation In Connection With Sale Of Company To Royal DSM N.V. – MATK - Business Wire 12.21.10 | 05:12 pm
- Faruqi & Faruqi, LLP Announces Shareholder Investigation Related To The Acquisition Of Martek Biosciences Corp. - MATK - Business Wire 12.21.10 | 05:12 pm
- Finkelstein Thompson LLP Announces Investigation Of Martek Biosciences Corp. - Business Wire 12.21.10 | 01:12 pm
- Law Office Of Jonathan M. Stein, P.L. Investigates Possible Breach Of Fiduciary Duty By The Board Of Martek Biosciences Corporation - Business Wire 12.21.10 | 12:12 pm
Partner Headlines for MATK
- Merger Arbitrage Mondays: March 07, 2011 - Seeking Alpha 03.07.11 | 09:03 am
- My Top 20 Portfolio Picks to Start the Year - Seeking Alpha 01.02.11 | 06:01 am
- UPDATE 1-SEC sues unknown buyers of Martek securities - Reuters 12.22.10 | 04:12 pm
- Stock Market News for Dec 22, 2010 - Market News - Zacks 12.22.10 | 10:12 am
- Company News for December 21, 2010 - Corporate Summary - Zacks 12.21.10 | 10:12 am
- UPDATE 1-Martek to sell most of Kentucky plant for $14 mln - Reuters 09.23.10 | 05:09 pm
- Martek Tops Zacks Consensus - Analyst Blog - Zacks 09.02.10 | 05:09 pm
- Competitive Technologies: Short Squeeze Coming or Another Leg Down? - Seeking Alpha 08.25.10 | 09:08 am
- UPDATE 1-Martek says to cut jobs at Winchester facility - Reuters 06.30.10 | 05:06 pm
- Call Volume Grows on Martek Biosciences (MATK) - Benzinga 06.04.10 | 01:06 pm
